For research use only. Not for therapeutic Use.
Aurora Kinases-IN-3 (Cat No.: I042455) is a potent and selective small molecule inhibitor targeting Aurora kinases, key regulators of mitosis and cell division. By inhibiting Aurora A, B, and/or C kinases, it disrupts proper chromosome alignment, segregation, and cytokinesis, leading to cell cycle arrest and apoptosis. Aurora Kinases-IN-3 is widely used in cancer research to explore mitotic control mechanisms and evaluate novel therapeutic strategies for tumors characterized by high proliferative activity. Its selectivity and efficacy make it a valuable experimental tool.
CAS Number | 2840558-83-8 |
Synonyms | 3-[3-(2-methoxypyridin-4-yl)pyridin-2-yl]oxy-N-methyl-5-(trifluoromethoxy)benzamide |
Molecular Formula | C20H16F3N3O4 |
Purity | ≥95% |
InChI | InChI=1S/C20H16F3N3O4/c1-24-18(27)13-8-14(11-15(9-13)30-20(21,22)23)29-19-16(4-3-6-26-19)12-5-7-25-17(10-12)28-2/h3-11H,1-2H3,(H,24,27) |
InChIKey | NVMJCTQSUKIXBG-UHFFFAOYSA-N |
SMILES | CNC(=O)C1=CC(=CC(=C1)OC(F)(F)F)OC2=C(C=CC=N2)C3=CC(=NC=C3)OC |
Reference | [1]. Lv G, et al. 2-Phenoxy-3, 4′-bipyridine derivatives inhibit AURKB-dependent mitotic processes by disrupting its localization. Eur J Med Chem. 2023 Jan 5;245(Pt 1):114904. |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |